Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Tory McJunkin

Pain Medicine Scottsdale, AZ Medical Doctor

NPI 1093850323 CMS profile 95143

9787 N 91St St, Suite 101, Scottsdale, AZ 85258

Open in the dashboard

General payments

$204,353

451 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$13,491 paid to institutions, not to them · program years 2019–2021

Through program year 2025, Tory McJunkin of Scottsdale, AZ is reported in the CMS Open Payments database as having received $204,353 across 451 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $13,491 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $5,361 9
2024 General $7,450 30
2023 General $35,233 72
2022 General $40,593 72
2021 General $18,163 71
2020 General $26,767 67
2019 General $70,785 130

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Tory McJunkin
  • Pain Medicine median
  • Middle half of Pain Medicine
  • National median

In program year 2025, general payments to Tory McJunkin were reported at $5,361. Among 2,779 Pain Medicine profiles paid that year, the median was $458 and the middle half received between $124 and $1,401.

Show as a table
Year Tory McJunkin Pain Medicine median Middle half National median
2019 $70,785 $498 $126–$1,682 $163
2020 $26,767 $284 $80–$910 $114
2021 $18,163 $399 $112–$1,219 $132
2022 $40,593 $455 $137–$1,484 $149
2023 $35,233 $484 $128–$1,495 $160
2024 $7,450 $498 $131–$1,540 $164
2025 $5,361 $458 $124–$1,401 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Nevro Corp. $185,810 292 payments
  2. Omnia Medical, LLC $7,251 2 payments
  3. Globus Medical, Inc. $4,839 3 payments
  4. Axonics Modulation Technologies, Inc. $3,040 68 payments
  5. Boston Scientific Corporation $1,183 25 payments
  6. Abbott Laboratories $843 24 payments
  7. Vertiflex, Inc. $351 6 payments
  8. Medtronic, Inc. $283 2 payments
  9. Nalu Medical, Inc. $210 7 payments
  10. Painteq LLC $134 1 payment
  11. Other $410 21 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $50,280 35 payments
  2. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $47,675 16 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $45,200 13 payments
  4. Travel and Lodging $27,583 60 payments
  5. Compensation for serving as faculty or as a speaker for a medical education program $20,400 11 payments
  6. Food and Beverage $12,958 315 payments
  7. Honoraria $258 1 payment
Products named General payments · program years 2019–2025
  1. Senza Spinal Cord Stimulation System $96,141 155 payments
  2. Omnia $57,645 100 payments
  3. Senza Spinal Cord Stimulator $31,155 21 payments
  4. Senza Spinal Cord Stimulator $4,839 3 payments
  5. Axonics $2,755 61 payments
  6. Senza Spinal Cord Stimulator $723 15 payments
  7. Superion ISS $351 6 payments
  8. General - Pain Management $255 3 payments
  9. Superion $228 6 payments
  10. Nalu Neurostimulation System $210 7 payments
  11. Other $2,946 74 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

125

Median for Anesthesiology: 322

Drug cost

$458

Median for Anesthesiology: $8,738

Branded share of claims

0%

Median for Anesthesiology: 25.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Cefadroxil Generic 97 $412
Oxybutynin Chloride Generic 28 $46

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,517 Part D prescribers listed as Anesthesiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 11 billing codes

Paid by Medicare

$91,492

Medicare's payments for the services billed

Medicare patients

230

Average age 77

Services billed

806

161 women, 69 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 67%
Depression 40%
Diabetes 31%
Ischemic heart disease 31%
Chronic kidney disease 31%
COPD 24%
Cancer 23%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

451 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pain Medicine in Arizona

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record